blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2493312

EP2493312 - SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRASE INHIBITOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.08.2022
Database last updated on 19.03.2026
FormerThe patent has been granted
Status updated on  17.09.2021
FormerGrant of patent is intended
Status updated on  06.05.2021
FormerExamination is in progress
Status updated on  09.03.2021
FormerGrant of patent is intended
Status updated on  08.11.2020
FormerExamination is in progress
Status updated on  22.12.2017
Most recent event   Tooltip26.08.2022No opposition filed within time limitpublished on 28.09.2022  [2022/39]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2012/36]
Inventor(s)01 / MAHJOUR, Majid
770 Sumneytown Pike
West Point, Pennsylvania 19486 / US
02 / LI, Feng
770 Sumneytown Pike
West Point, Pennsylvania 19486 / US
03 / MA, Decheng
770 Sumneytown Pike
West Point, Pennsylvania 19486 / US
04 / SOTTHIVIRAT, Sutthilug
770 Sumneytown Pike
West Point, Pennsylvania 19486 / US
 [2012/36]
Representative(s)Böhles, Elena
Merck Sharp & Dohme (UK) Limited
120 Moorgate
London EC2M 6UR / GB
[N/P]
Former [2021/42]Böhles, Elena
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
Former [2012/36]Böhles, Elena
Merck & Co., Inc.
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date10827338.421.10.2010
[2021/42]
WO2010US53507
Priority number, dateUS20090254869P26.10.2009         Original published format: US 254869 P
[2012/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011053504
Date:05.05.2011
Language:EN
[2011/18]
Type: A1 Application with search report 
No.:EP2493312
Date:05.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 05.05.2011 takes the place of the publication of the European patent application.
[2012/36]
Type: B1 Patent specification 
No.:EP2493312
Date:20.10.2021
Language:EN
[2021/42]
Search report(s)International search report - published on:US05.05.2011
(Supplementary) European search report - dispatched on:EP10.06.2013
ClassificationIPC:A61K9/20, A61K31/513, A61K45/06, A61K9/24, A61P31/18, A61K31/506, A61P43/00
[2020/48]
CPC:
A61K31/513 (EP,CN,KR,RU,US); A61K31/4245 (RU); A61K9/2077 (EP,CN,KR,RU,US);
A61K9/2054 (EP,CN,US); A61J3/10 (RU); A61K31/506 (EP,KR,US);
A61K45/06 (EP,CN,US); A61K47/00 (RU); A61K9/0053 (RU);
A61K9/2009 (US); A61K9/2013 (US); A61K9/209 (EP,KR,US);
A61K9/2095 (RU,US); A61P31/18 (EP); A61P43/00 (EP);
A61K2121/00 (RU) (-)
C-Set:
A61K31/506, A61K2300/00 (EP);
A61K31/513, A61K2300/00 (CN,EP)
Former IPC [2013/28]A61K9/20, A61K31/513, A61K45/06, A61P31/18, A61K9/24
Former IPC [2012/36]A01N43/78, A61K31/425
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/36]
Extension statesBA29.05.2012
ME29.05.2012
TitleGerman:FESTE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINEM INTEGRASEHEMMER[2012/36]
English:SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRASE INHIBITOR[2012/36]
French:COMPOSITIONS PHARMACEUTIQUES SOLIDES CONTENANT UN INHIBITEUR D'INTÉGRASE[2012/36]
Entry into regional phase29.05.2012National basic fee paid 
29.05.2012Search fee paid 
29.05.2012Designation fee(s) paid 
29.05.2012Examination fee paid 
Examination procedure29.05.2012Examination requested  [2012/36]
23.12.2013Amendment by applicant (claims and/or description)
20.12.2017Despatch of a communication from the examining division (Time limit: M06)
28.06.2018Reply to a communication from the examining division
31.01.2020Despatch of a communication from the examining division (Time limit: M06)
31.07.2020Reply to a communication from the examining division
09.11.2020Communication of intention to grant the patent
09.03.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
07.05.2021Communication of intention to grant the patent
08.09.2021Fee for grant paid
08.09.2021Fee for publishing/printing paid
08.09.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21202505.0  / EP3970702
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.12.2017
Opposition(s)21.07.2022No opposition filed within time limit [2022/39]
Fees paidRenewal fee
05.10.2012Renewal fee patent year 03
07.10.2013Renewal fee patent year 04
07.10.2014Renewal fee patent year 05
07.10.2015Renewal fee patent year 06
07.10.2016Renewal fee patent year 07
10.10.2017Renewal fee patent year 08
08.10.2018Renewal fee patent year 09
08.10.2019Renewal fee patent year 10
09.10.2020Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC20.10.2021
SM20.10.2021
[2022/33]
Documents cited:Search[X] WO2007087188  (MERCK & CO INC et al.) [X] 1-25 * examples 3,4 * * page 26 - page 27 *
 [I] US2007292504  (POURKAVOOS NAZANEEN et al.) [I] 1-25 * examples 3-8 *
International search[Y] US2008118559  (CRUANES MARIA T et al.) [Y]
 [Y] WO2008043167  (PHARMASCIENCE INC et al.) [Y]
 [YP]   "Avicel DG binder: A superior excipient for roller compaction and dry granulation", FMC BIOPOLYMER., 29 October 2009 (2009-10-29), pages 2 [YP]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.